PEPTIDES·INDEX
72 peptides412 listingsUpdated 56m agoBuild My Stack
Library

AdamaxNootropic

Adamantane-modified Semax analog sold as a nootropic; no published studies of it exist.

Rating1/5SpeculativeHuman dataSafety
Compare prices — from $53.10
StatusResearch only
FDA-approvedNO
PrescriptionNO
From$53.10

Overview

Adamax is a research-market analog of Semax, the Russian ACTH(4-10)-derived nootropic peptide, marketed as Semax with an N-terminal acetyl group and an adamantane group added to increase stability and lipophilicity. No peer-reviewed study of Adamax itself has been published — not in humans and not in animals — so every claim about it is extrapolated from Semax, whose own evidence is mostly Russian and preclinical (the sources below are Semax studies, not Adamax studies). It is not FDA-evaluated and is sold for laboratory research only; nothing here is medical or dosing advice.

Related compounds

Methylene BlueNootropicResearch compound studied for mitochondrial and cognitive effects.DihexaNootropicPeptide studied for synapse formation and memory.SemaxNootropicNootropic peptide studied for cognition and recall.PinealonNootropicPeptide bioregulator studied for brain function.

Sources

Starting references for the library summary. These are not dosing instructions or medical advice.

A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)Zhurnal Vysshei Nervnoi Deyatelnosti imeni I P Pavlovapubmed.ncbi.nlm.nih.gov/9173745/…Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrainJournal of Neurochemistrypubmed.ncbi.nlm.nih.gov/16635254/…

For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.